Quintet Private Bank (Europe) S.A. Moderna, Inc. Transaction History
Quintet Private Bank (Europe) S.A.
- $1.72 Trillion
- Q2 2024
A detailed history of Quintet Private Bank (Europe) S.A. transactions in Moderna, Inc. stock. As of the latest transaction made, Quintet Private Bank (Europe) S.A. holds 732 shares of MRNA stock, worth $46,233. This represents 0.01% of its overall portfolio holdings.
Number of Shares
732
Previous 715
2.38%
Holding current value
$46,233
Previous $87.1 Million
12.15%
% of portfolio
0.01%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding MRNA
# of Institutions
1,114Shares Held
241MCall Options Held
9.26MPut Options Held
12.1M-
Baillie Gifford & CO43.4MShares$2.74 Billion4.1% of portfolio
-
Vanguard Group Inc Valley Forge, PA39.6MShares$2.5 Billion0.09% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$1.61 Billion0.07% of portfolio
-
State Street Corp Boston, MA15MShares$949 Million0.08% of portfolio
-
Theleme Partners LLP London, X07.23MShares$456 Million42.67% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $24.7B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...